Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (SE:VITR)
:VITR
Earnings Data
Report Date
Feb 03, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
―Last Year’s EPS
1.03Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects a company that is navigating difficult macroeconomic conditions with strategic investments and strong growth in certain regions, particularly the Americas. However, challenges such as currency impacts, regional difficulties in China, and increased operating expenses weigh on the overall performance.Company Guidance
Organic Growth Amid Challenges
Vitrolife delivered a 5% organic growth in local currencies, excluding discontinued business, despite facing macroeconomic and geopolitical challenges in the reproductive health industry.
Strong Performance in Americas
Sales in the Americas increased by 11% in local currencies with strong growth across the entire portfolio and in all markets, marking the strongest quarter in 11 quarters.
Stable Gross and EBITDA Margins
Gross margin slightly increased to 58.9%, and EBITDA was SEK 253 million, with an EBITDA margin of 30.3%, showing resilience despite negative currency impacts.
Positive Developments in EMEA and APAC
EMEA showed a 4% growth in local currencies, excluding discontinued business, and APAC recorded its first positive quarter of the year with 1% organic growth.
Operational Cash Flow
The company reported a strong operating cash flow of SEK 255 million, benefiting from positive contributions from net working capital.
SE:VITR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:VITR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 17, 2025 | kr151.30 | kr142.00 | -6.15% |
Apr 24, 2025 | kr155.26 | kr143.44 | -7.61% |
Jan 30, 2025 | kr226.53 | kr233.28 | +2.98% |
Oct 24, 2024 | kr234.47 | kr239.83 | +2.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Vitrolife AB (SE:VITR) report earnings?
Vitrolife AB (SE:VITR) is schdueled to report earning on Feb 03, 2026, Before Open (Confirmed).
What is Vitrolife AB (SE:VITR) earnings time?
Vitrolife AB (SE:VITR) earnings time is at Feb 03, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Vitrolife AB stock?
The P/E ratio of Vitrolife AB is N/A.
What is SE:VITR EPS forecast?
Currently, no data Available